Tick-borne Encephalitis Clinical Trial
Official title:
Characterization of Humoral and Cellular Immunity of Low and High-responders After TBE Vaccination
The phenomenon of no- and low-responsiveness has been described after applications of
different vaccines (e.g. hepatitis B, TBE) and is concerning about 2-10% of the vaccinees.
The aim of this project is to investigate the humoral and cellular immune responses of
low-responders after TBE vaccination in order to find parameters regarding immunoregulation
against TBE. It is of interest if non-responsiveness is a general immunological deficit of a
distinct patient group or if it is a antigen-specific phenomenon.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01031537 -
Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)
|
Phase 2 | |
| Recruiting |
NCT02463942 -
Tick-borne Encephalitis and Positive Borrelial Antibodies
|
N/A | |
| Completed |
NCT01361776 -
Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
|
Phase 2/Phase 3 | |
| Completed |
NCT00161863 -
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
|
Phase 3 | |
| Completed |
NCT00161798 -
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
|
Phase 2 | |
| Recruiting |
NCT05607394 -
Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases
|
||
| Completed |
NCT01710189 -
Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac
|
Phase 4 | |
| Completed |
NCT00161772 -
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
|
Phase 2 | |
| Completed |
NCT00161785 -
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
|
Phase 4 | |
| Completed |
NCT00118924 -
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
|
Phase 1 | |
| Recruiting |
NCT05941546 -
Tick-borne Encephalitis Virus Research in Limousin
|
||
| Not yet recruiting |
NCT04573205 -
Primary TBE Vaccination for the Elderly
|
Phase 4 | |
| Completed |
NCT02318069 -
New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
|
Phase 2/Phase 3 | |
| Completed |
NCT04648241 -
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
|
Phase 3 |